NORTH CHICAGO, Ill., Oct. 17, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved...
Vous n'êtes pas connecté
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
NORTH CHICAGO, Ill., Oct. 17, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved...
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT
Updated Date: Thu, 24 Oct 2024 00:00:00 EDT